HER IMPROVED FOCUS STARTED WITH VYVANSE.1 VYVANSE STARTED WITH YOU.

Vyvanse demonstrated significant improvement in attention in adults with ADHD.1

Hypothetical patient portrayal. Individual results may vary.

ABOUT ADHD IN ADULTS

While it may not be easy for your patients to talk about their ADHD symptoms, we offer tips alongside DSM-5® diagnostic criteria that can help start the conversation and support ADHD patient care.

ONCE-DAILY DOSING & CUSTOMIZABLE ADMINISTRATION

Vyvanse has once-daily dosing and only Vyvanse (lisdexamfetamine dimesylate) has 5 administration options, so you can tailor treatment to meet the needs of your patients with ADHD.1

You get the best resources.

Hypothetical patient portrayal

YOU CAN FIND EXTENSIVE RESOURCES

When it comes to keeping you well-informed about treatment and symptom management options for your patients, our ADHD resource center is available and ready to help.

Help your eligible patients start saving.

Hypothetical patient portrayal

SHOW YOUR ELIGIBLE PATIENTS HOW THEY COULD SAVE

You’re dedicated to your patients. We’re dedicated to providing a savings offer to help make Vyvanse prescriptions accessible to them. See details. Restrictions apply.

Hypothetical patient portrayal

KEEP IN TOUCH

Stay up to date with the latest information and resources to help support your Vyvanse patients.

New patients from June 2008* to present for all approved indications.

*Vyvanse (lisdexamfetamine dimesylate) has been approved to treat ADHD in adults since 2008.2

References
  1. Vyvanse [package insert]. Lexington, MA: Shire US Inc.
  2. US Food and Drug Administration. Vyvanse supplement approval letter for attention deficit hyperactivity disorder in the adult population. https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021977s001ltr.pdf. April 2008. Accessed February 19, 2020.

INDICATION AND IMPORTANT SAFETY INFORMATION